Minnesota SF 5290: Addition requirement for certain pharmaceutical marketing expenses

Status: Referred to Taxes (as of 2026-05-13)

State: Minnesota · Session: 2025-2026 · Bill: SF 5290

Subjects: Taxation, Taxation-Corporate, Taxation-Income

Sponsors: Klein

View Minnesota SF 5290 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.